Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

Teva
Favicon Fierce Biotech

Teva saddles up as bidder for bankrupt BioXcel’s CNS assets

BioXcel Therapeutics has filed for bankruptcy and lined up a deal for Teva Pharmaceutical to acquire its assets for $57.5 million upfront.
Nick Paul Taylor Aug 28, 2026 9:17am
Room

‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters

Aug 5, 2026 10:12am
blocks coins money

Editor’s Corner: Why an AZ-BMS merger would be a very bad idea

Aug 3, 2026 12:25am
Belen Garijo Sanofi Merck KGaA
Favicon Fierce Biotech

Sanofi CEO ‘looking deeply’ at pipeline as clearout continues

Jul 30, 2026 3:27am
AstraZeneca

AstraZeneca buys lung cancer drug Zegfrovy from Dizal for $1.5B

Jul 14, 2026 9:57am
Catalent

Catalent sells UK facility, expands Nanoscope partnership

Jul 8, 2026 9:25am